Magnetar Financial LLC Fulgent Genetics, Inc. Transaction History

Magnetar Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$19.09 - $22.57 $249,849 - $295,396	13,088 New	13,088 $256,000
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $255,681 - $378,621	-3,415 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$66.8 - $100.45 $42,885 - $64,488	-642 Reduced 15.82%	3,415 $315,000
Q1 2021 May 14, 2021	BUY	$59.3 - $183.85 $240,580 - $745,879	4,057 New	4,057 $392,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.